MAPT and Alzheimer disease: Like humans with AD [28, 29], these mice show evidence for network hyperexcitability, and suppression of this network hyperexcitability by tau reduction or treatment with the antiepileptic drug levetiracetam prevents or ameliorates synaptic and behavioral abnormalities in these models [1, 2, 30].